Is CDG Petchem overvalued or undervalued?

As of 14 August 2024, CDG Petchem's valuation grade has moved from attractive to risky, indicating a significant deterioration in its financial health. The company appears to be overvalued, particularly given its troubling headline ratios, including a PE ratio of -12.33, an EV to EBIT of -18.03, and a ROE of -170.00%. These figures suggest severe operational challenges and negative profitability, which are concerning for potential investors. In comparison to its peers, CDG Petchem stands out unfavorably; for instance, Supreme Industries has a PE ratio of 57.34 and EV to EBITDA of 37.87, while Finolex Industries shows a PE of 28.37 and EV to EBITDA of 24.37. This stark contrast highlights CDG Petchem's underperformance in the industry. Additionally, the company's recent stock performance has been lackluster, with a year-to-date return of -19.25%, significantly trailing the Sensex's gain of 5.59%. Overall, the current metrics suggest that CDG Petchem is not a viable investment at this time.